As of 2024-07-27, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 53.21 mil USD. AXDX's TTM EBITDA according to its financial statements is -44.24 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 20.5x | 19.6x |
| Forward P/E multiples | 19.3x - 21.9x | 20.5x |
| Fair Price | (39.83) - (42.20) | (41.34) |
| Upside | -3164.1% - -3346.2% | -3279.8% |
| Date | EV/EBITDA |
| 2024-07-26 | -1.20 |
| 2024-07-25 | -1.17 |
| 2024-07-24 | -1.18 |
| 2024-07-23 | -1.20 |
| 2024-07-22 | -1.13 |
| 2024-07-19 | -1.11 |
| 2024-07-18 | -1.12 |
| 2024-07-17 | -1.13 |
| 2024-07-16 | -1.12 |
| 2024-07-15 | -1.13 |
| 2024-07-12 | -1.13 |
| 2024-07-11 | -1.11 |
| 2024-07-10 | -1.12 |
| 2024-07-09 | -1.13 |
| 2024-07-08 | -1.14 |
| 2024-07-05 | -1.13 |
| 2024-07-03 | -1.14 |
| 2024-07-02 | -1.13 |
| 2024-07-01 | -1.14 |
| 2024-06-28 | -1.14 |
| 2024-06-27 | -1.13 |
| 2024-06-26 | -1.14 |
| 2024-06-25 | -1.14 |
| 2024-06-24 | -1.18 |
| 2024-06-21 | -1.19 |
| 2024-06-20 | -1.18 |
| 2024-06-18 | -1.13 |
| 2024-06-17 | -1.19 |
| 2024-06-14 | -1.23 |
| 2024-06-13 | -1.22 |
| 2024-06-12 | -1.19 |
| 2024-06-11 | -1.18 |
| 2024-06-10 | -1.18 |
| 2024-06-07 | -1.20 |
| 2024-06-06 | -1.16 |
| 2024-06-05 | -1.18 |
| 2024-06-04 | -1.13 |
| 2024-06-03 | -1.16 |
| 2024-05-31 | -1.15 |
| 2024-05-30 | -1.21 |
| 2024-05-29 | -1.29 |
| 2024-05-28 | -1.29 |
| 2024-05-24 | -1.24 |
| 2024-05-23 | -1.19 |
| 2024-05-22 | -1.08 |
| 2024-05-21 | -1.09 |
| 2024-05-20 | -0.99 |
| 2024-05-17 | -0.99 |
| 2024-05-16 | -1.01 |
| 2024-05-15 | -1.01 |